In the changed post COVID-19 business landscape, the global market for Recombinant DNA Technology estimated at US$74. 5 Billion in the year 2020, is projected to reach a revised size of US$94. 7 Billion by 2027, growing at aCAGR of 3.

New York, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Recombinant DNA Technology Industry" - https://www.reportlinker.com/p06032744/?utm_source=GNW
5% over the period 2020-2027. Medical, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$71.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Medical segment is readjusted to a revised 2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $21.8 Billion, While China is Forecast to Grow at 3.2% CAGR

The Recombinant DNA Technology market in the U.S. is estimated at US$21.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$16.7 Billion by the year 2027 trailing a CAGR of 3.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Select Competitors (Total 32 Featured) -
Amgen Inc
Bamboo Therapeutics, Inc.
Biocon
Biogen
Chiron Corporation
Cibus
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Genentech, Inc
GenScript
GlaxoSmithKline plc.
Horizon Discovery Group plc
Merck KGaA
Monsanto Company
New England Biolabs
Novartis AG
Novo Nordisk A/S
Nucelis
Pfizer Inc.
Profacgen
Sanofi
Syngene


Read the full report: https://www.reportlinker.com/p06032744/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Recombinant DNA Technology - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Recombinant DNA Technology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Recombinant DNA
Technology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Medical by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Medical by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Medical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Non-Medical by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Non-Medical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Non-Medical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Expression System by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Expression System by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Expression System by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Cloning Vector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Cloning Vector by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Cloning Vector by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Health & Disease by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Health & Disease by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Health & Disease by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Environmental by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 28: World Recombinant DNA Technology Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
Table 29: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 30: USA Historic Review for Recombinant DNA Technology by
Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 31: USA 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 32: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 33: USA Historic Review for Recombinant DNA Technology by
Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 34: USA 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 35: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 36: USA Historic Review for Recombinant DNA Technology by
Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 37: USA 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 40: Canada 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 41: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Canada Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 44: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 45: Canada Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 46: Canada 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

JAPAN
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 49: Japan 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 50: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 51: Japan Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 52: Japan 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 53: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 54: Japan Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 55: Japan 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

CHINA
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Table 56: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 57: China Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 58: China 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 59: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 60: China Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 61: China 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 62: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 63: China Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 64: China 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

EUROPE
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 66: Europe Historic Review for Recombinant DNA Technology
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 67: Europe 15-Year Perspective for Recombinant DNA
Technology by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2021 & 2027

Table 68: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 69: Europe Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 70: Europe 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 71: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 72: Europe Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 73: Europe 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 74: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 75: Europe Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 76: Europe 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

FRANCE
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 77: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 78: France Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 79: France 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 80: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 81: France Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: France 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 83: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 84: France Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 85: France 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

GERMANY
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 87: Germany Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: Germany 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 89: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 90: Germany Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 91: Germany 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 92: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 93: Germany Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 94: Germany 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 96: Italy Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 97: Italy 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 98: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 99: Italy Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 100: Italy 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 101: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 102: Italy Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 103: Italy 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

UNITED KINGDOM
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2022
(E)
Table 104: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 105: UK Historic Review for Recombinant DNA Technology by
Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 106: UK 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 107: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 108: UK Historic Review for Recombinant DNA Technology by
Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 109: UK 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 110: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 111: UK Historic Review for Recombinant DNA Technology by
Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 112: UK 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

REST OF EUROPE
Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Product Type -
Medical and Non-Medical - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 114: Rest of Europe Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 115: Rest of Europe 15-Year Perspective for Recombinant
DNA Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Type - Expression
System and Cloning Vector - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 117: Rest of Europe Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 118: Rest of Europe 15-Year Perspective for Recombinant
DNA Technology by Type - Percentage Breakdown of Value Sales
for Expression System and Cloning Vector for the Years 2012,
2021 & 2027

Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Application - Health &
Disease, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 120: Rest of Europe Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 121: Rest of Europe 15-Year Perspective for Recombinant
DNA Technology by Application - Percentage Breakdown of Value
Sales for Health & Disease, Food & Agriculture, Environmental
and Other Applications for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 123: Asia-Pacific Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 124: Asia-Pacific 15-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2012, 2021 &
2027

Table 125: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 126: Asia-Pacific Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 127: Asia-Pacific 15-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2012, 2021 &
2027

Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Application - Health &
Disease, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 129: Asia-Pacific Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 130: Asia-Pacific 15-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2012, 2021 & 2027

REST OF WORLD
Table 131: Rest of World Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 132: Rest of World Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032744/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001